Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Nevada Sunrise Identifies Gold-in-Soil Anomalies over New Target Areas at the Griffon Gold Mine Project, Nevada
-
Fuerte Metals Begins 40,000 m Drilling Program at the Coffee Gold Project
-
BCM Resources Commences Core Tail Drilling at its 100% Controlled Thompson Knolls Porphyry-Skarn Project, Utah
-
SOL Global Announces Resignation of Auditor, Anticipated Cease Trade Order and Postponement of Annual Meeting
-
Avalon Advanced Materials Appoints Burl Joseph as Project Director to Advance the Nechalacho REE & Zirconium Project Toward Execution
-
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
-
AbraSilver Completes Condoryacu Acquisition; Intersects 72 Metres Grading 18.7 g/t Gold, 117 g/t Silver and 2.06% Copper from Surface
-
Thunder Gold Acknowledges $215,000 in Funding from Ontario Junior Exploration Program (OJEP)
-
Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment
-
Spring Starts in the Bedroom: PHF Unveils Performance-Driven Breathable Bedding Collection for 2026
-
Alset AI Announces Trading on the OTCQB Venture Market in the United States and 10-for-1 Share Consolidation to Enhance Shareholder Value
-
TVBuddy Smart TV Remote App Review: I Ditched My Physical Remote for 30 Days
-
Investor Frenzy: APEMARS Skyrockets as Top Crypto To Watch Now With ROI While Dogecoin and Snek Hold Steady
-
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations
-
SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026
-
Soluna Reports Record 2025 Growth: Pipeline Hits 4.3GW, Raises $142 Million, and Launches AI Infrastructure
-
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
-
Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204
-
PHINIA Inc. to Report Q1 2026 Earnings
-
Capstone Expands Commercial Market Reach with KLAD Integration, Unlocking High-Margin, Asset-Light Revenue Growth
-
Drilling intersects 92.6 metres (m) of 0.95 g/t gold
-
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
-
ProCap Financial Stockholders Approve Acquisition of AI Agent Lab CFO Silvia
-
Canopy Growth’s Apollo Cannabis Clinics Named Best Medical Cannabis Clinic
-
BTQ Technologies to Host Live Webinar on 2025 Financial Results and General Corporate Update
-
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
-
Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants
-
AGNICO EAGLE PROVIDES NOTICE OF RELEASE OF FIRST QUARTER 2026 RESULTS, CONFERENCE CALL AND ANNUAL MEETING
-
Jack in the Box Inc. Announces Katelyn Zborowski as Chief Marketing Officer
-
Cass Commercial Bank Names Eric Giering President
-
InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting
-
Bitfarms to Participate in Jefferies Fireside Chat
-
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
-
Bombardier Announces Extension of Consent Solicitation with Respect to its 7.35% Debentures due 2026
-
BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9
-
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
-
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
-
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Marimaca Announces the Appointment of Zenon Wozniak to its Board of Directors; Giancarlo Bruno appointed Independent Non-Executive Chair; Board Changes
-
Anavex Life Sciences Provides Comprehensive Regulatory Update
-
Aehr Test Systems to Announce Third Quarter Fiscal 2026 Financial Results on April 7, 2026
-
Sol-Millennium Medical Inc. Launches U.S. B2B eShop, Providing Direct Access to Safety Engineered Medical Devices Nationwide
-
Capitalzodiac Unveils "Geo-Matrix" – A Revolutionary Analytical Framework for the Global Strategic Minerals Sector
-
Capitalzodiac Unveils "Geo-Matrix" – A Revolutionary Analytical Framework for the Global Strategic Minerals Sector
-
NEURONES: Declaration of transactions on treasury shares (March 23 to 27, 2026)
-
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
-
DriverAI Mileage Tracking App Review: Smart Automation That Actually Works
-
Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026
-
Appili Therapeutics to Exhibit at World Vaccine Congress Washington
-
BLUENERGIES ANNOUNCES TRADING ON OTCQX BEST MARKET UNDER THE TRADING SYMBOL "BLUGF"
